Reuters Market Eye - Shares in SeQuent Scientific Ltd
Morgan Stanley Asia, Merrill Lynch Capital Markets Espana and Route One Fund bought about 0.4 million shares each at 250 rupees per share, BSE data shows.
SeQuent is engaged in the development and manufacture of pharmaceuticals and speciality chemicals.
(Reporting by Abhishek Vishnoi)